Literature DB >> 24831411

Predictors of all-cause mortality in patients with stable COPD: medical co-morbid conditions or high depressive symptoms.

Gemma A Maters1, Jacob N de Voogd, Robbert Sanderman, Johan B Wempe.   

Abstract

Co-morbid conditions are frequently found in patients with COPD. We evaluate the association of co-morbidities with mortality, in stable COPD. 224 patients, mean age 61.2 (± 10.00), 48.2% female, mean FEV1 1.1 (± 0.5) liters, median follow-up time 4.2 years, participated. Medical co-morbidities were scored according to the Charlson Co-morbidity Index (CCI). Depressive symptoms were assessed with the Hospital Anxiety and Depression Scale (HADS) and Symptom Checklist-90 (SCL-90). The Cox proportional hazard model was used for survival analyses. In our sample, 70% of all patients have a co-morbid medical condition or high depressive symptoms. During follow-up 51% of all patients died, and those with heart failure have the highest mortality rate (75%). Age, fat-free mass and exercise capacity were predictive factors, contrary to CCI-scores and high depressive symptoms. An unadjusted association between heart failure and survival was found. Although the presence of co-morbidities, using the CCI-score, is not related to survival, heart failure seems to have a detrimental effect on survival. Higher age and lower exercise capacity or fat-free mass predict mortality.

Entities:  

Keywords:  co-morbidity; depression; heart failure; survival

Mesh:

Year:  2014        PMID: 24831411     DOI: 10.3109/15412555.2014.898026

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  5 in total

1.  Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Oana L Klein; Larissa Aviles-Santa; Jianwen Cai; Harold R Collard; Alka M Kanaya; Robert C Kaplan; Gregory L Kinney; Eliana Mendes; Lewis Smith; Gregory Talavera; Donghong Wu; Martha Daviglus
Journal:  Diabetes Care       Date:  2016-09-09       Impact factor: 19.112

2.  Impact of anxiety and depression on the prognosis of copd exacerbations.

Authors:  Sandra Martínez-Gestoso; María-Teresa García-Sanz; José-Martín Carreira; Francisco-Javier Salgado; Uxío Calvo-Álvarez; Liliana Doval-Oubiña; Sandra Camba-Matos; Lorena Peleteiro-Pedraza; Miguel-Angel González-Pérez; Pedro Penela-Penela; Andrés Vilas-Iglesias; Francisco-Javier González-Barcala
Journal:  BMC Pulm Med       Date:  2022-04-29       Impact factor: 3.320

3.  Influence of COPD systemic environment on the myogenic function of muscle precursor cells in vitro.

Authors:  Carme Casadevall; Antonio Sancho-Muñoz; Ignacio Vicente; Sergi Pascual-Guardia; Mireia Admetlló; Joaquim Gea
Journal:  Respir Res       Date:  2022-10-14

Review 4.  Palliative care in COPD: an unmet area for quality improvement.

Authors:  Julia H Vermylen; Eytan Szmuilowicz; Ravi Kalhan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-06

5.  Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.

Authors:  Haiyan Ge; Xuanqi Liu; Wenchao Gu; Xiumin Feng; Fengying Zhang; Fengfeng Han; Yechang Qian; Xiaoyan Jin; Beilan Gao; Li Yu; Hong Bao; Min Zhou; Shengqing Li; Zhijun Jie; Jian Wang; Zhihong Chen; Jingqing Hang; Jingxi Zhang; Huili Zhu
Journal:  J Inflamm Res       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.